What do diet-induced changes in phase I and II enzymes tell us about prevention from exposure to heterocyclic amines?

Journal of Nutrition

Volumn 136, Issue 10, 2006, Pages

  Felton, James S ^a   Malfatti, Michael A ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 6 PHENYL 1H IMIDAZO[4,5 B]PYRIDIN 2 AMINE; ACYLTRANSFERASE; CARCINOGEN; GLUCURONOSYLTRANSFERASE; HETEROCYCLIC AMINE; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

CANCER; CANCER PREVENTION; CANCER RISK; CONFERENCE PAPER; DIET THERAPY; DIETARY INTAKE; DNA DAMAGE; GILBERT DISEASE; HUMAN;

EID: 33749481201     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.10.2683s     Document Type: Conference Paper

References (9)

1. Knize MG, Felton JS. Formation and human risk of carcinogenic heterocyclic amines formed from natural precursors in meat. Nutr Rev. 2005;63:158-65.
2. Kulp KS, Fortson SL, Knize MG, Felton JS. An in vitro model system to predict the bioaccessibility of heterocyclic amines from a cooked meat matrix. Food Chem Toxicol. 2003;41:1701-10.
3. Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, disease. Annu Rev Pharmacol Toxicol. 2000;40:581-616.
4. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, deBoer A, Oostra BA, Lindhout D, Tygat GN, Jansen PL, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 1995;333:1171-5.
5. Miners JO, McKinnon RA, Mackenzie PI. Genetic polymorphisms of UDP-glucuronosyltransferase and their functional significance. Toxicology. 2002;181-182:453-6.
6. Girard H, Thibaudeau J, Court MH, Fortier L-C, Villeneuve L, Caron P, Hao Q, von Moltke LL, Greenblatt DJ, Guillemette C. UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liver. Hepatology. 2005;42:448-57.
7. Turesky RJ. Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis. Drug Metab Rev. 2002;34:625-50.
8. Bennion BJ, Cosman M, Lightstone FC, Knize MG, Montgomery JL, Bennett LM, Felton JS, Kulp KS. PhlP carcinogenicity in breast cancer: Computational and experimental evidence for competitive interactions with human estrogen receptor. Chem Res Toxicol. 2005;18(10):1528-36.
9. Malfatti MA, Wu RW, Felton JS. The effect of UDP-glucuronosyltransferase 1A1 expression on the mutagenicity and metabolism of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in CHO cells. Mutat Res. 2005;570:205-14.